CliffBio
small molecule

GALZIN

ZINC ACETATE

Loss of exclusivity—loss of exclusivity
CompanyEton Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameGALZIN
Active ingredientZINC ACETATE
StrengthEQ 25MG ZINC
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 1997
Marketing statusRX

More from Eton Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

GALZIN patent cliff — loss of exclusivity — | CliffBio